ANDA 79153, held by Torrent Pharms. Topiramate.
As of Nov 15, 2026, ANDA 79153 (Topiramate), held by Torrent Pharms, was first approved by FDA on Mar 27, 2009, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 27, 2009 | Original application | Approved |
| Topiramate25MG · tablet;oral | Topiramate | Discontinued |
| Topiramate50MG · tablet;oral | Topiramate | Discontinued |
| Topiramate100MG · tablet;oral | Topiramate | Discontinued |
| Topiramate200MG · tablet;oral | Topiramate | Discontinued |
| Jan 24, 2019 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jan 24, 2019 | Supplement 21Labeling · Standard review | Approved | None posted |
| Nov 30, 2015 | Supplement 17Labeling · Standard review | Approved | None posted |
| Dec 1, 2014 | Supplement 12Labeling | Approved | None posted |
| Dec 1, 2014 | Supplement 16Labeling · Standard review | Approved | None posted |
| Apr 29, 2013 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jul 14, 2011 | Supplement 8Labeling | Approved | None posted |
| Aug 11, 2010 | Supplement 6Labeling | Approved | None posted |
| Jan 22, 2010 | Supplement 2Labeling | Approved | None posted |
| Jan 22, 2010 | Supplement 3Labeling | Approved | None posted |
| Jan 21, 2010 | Supplement 4Manufacturing | Approved | None posted |
| Mar 27, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters